Jazz Pharmaceuticals plc
NASDAQ:JAZZ
Overview | Financials
Company Name | Jazz Pharmaceuticals plc |
Symbol | JAZZ |
Currency | USD |
Price | 110.45 |
Market Cap | 6,820,674,075 |
Dividend Yield | 0% |
52-week-range | 99.06 - 134.48 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Mr. Bruce C. Cozadd |
Website | https://www.jazzpharma.com |
An error occurred while fetching data.
About Jazz Pharmaceuticals plc
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement disorders; and in
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD